These findings collectively demonstrate that CHRDL1 functions as a metastasis suppressor in pancreatic cancer through specific inhibition of migration and adhesion processes, without influencing proliferative activity, thereby extending its known tumor-suppressive role beyond breast cancer to pancreatic malignancies. Here, CHRDL1 is linked to neoplasm.